What is a stock summary page? Click here for an overview.
Business Description
Jubilant Ingrevia Ltd
ISIN : INE0BY001018
Share Class Description:
BOM:543271: Ordinary SharesCompare
Compare
Traded in other countries / regions
543271.India IPO Date
2021-03-19Description
Jubilant Ingrevia Ltd is a life science products and solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. It is engaged in the manufacturing and supply of specialty intermediates, nutrition and health solutions, and life science chemicals. Its segments are Speciality Chemicals, Nutrition, and Health Solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Chemical Intermediaries segment which manufactures acetyls, and speciality ethanol. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.43 | |||||
| Interest Coverage | 5.83 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.99 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.1 | |||||
| 3-Year EBITDA Growth Rate | -10.9 | |||||
| 3-Year EPS without NRI Growth Rate | -21.3 | |||||
| 3-Year Book Growth Rate | 12.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 32.39 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.59 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.75 | |||||
| 9-Day RSI | 45.47 | |||||
| 14-Day RSI | 45.02 | |||||
| 3-1 Month Momentum % | -8.73 | |||||
| 6-1 Month Momentum % | -8.24 | |||||
| 12-1 Month Momentum % | 23.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 0.66 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 155.04 | |||||
| Days Sales Outstanding | 47.46 | |||||
| Days Payable | 117.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.79 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 0.79 | |||||
| 5-Year Yield-on-Cost % | 0.79 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | -0.69 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.49 | |||||
| Operating Margin % | 7.69 | |||||
| Net Margin % | 4.98 | |||||
| FCF Margin % | -3.34 | |||||
| ROE % | 7.5 | |||||
| ROA % | 4.41 | |||||
| ROIC % | 5.91 | |||||
| 3-Year ROIIC % | 10.67 | |||||
| ROC (Joel Greenblatt) % | 9.83 | |||||
| ROCE % | 10.21 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.5 | |||||
| Forward PE Ratio | 28.38 | |||||
| PE Ratio without NRI | 48.5 | |||||
| PS Ratio | 2.42 | |||||
| PB Ratio | 3.56 | |||||
| Price-to-Tangible-Book | 3.58 | |||||
| Price-to-Operating-Cash-Flow | 23.32 | |||||
| EV-to-EBIT | 30.51 | |||||
| EV-to-EBITDA | 21.15 | |||||
| EV-to-Revenue | 2.56 | |||||
| EV-to-FCF | -72.52 | |||||
| Price-to-GF-Value | 1.36 | |||||
| Price-to-Graham-Number | 3.01 | |||||
| Earnings Yield (Greenblatt) % | 3.28 | |||||
| FCF Yield % | -1.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jubilant Ingrevia Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 41,467.45 | ||
| EPS (TTM) (₹) | 13.05 | ||
| Beta | 0.91 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.52 | ||
| Volatility % | 44.35 | ||
| 14-Day RSI | 45.02 | ||
| 14-Day ATR (₹) | 34.142258 | ||
| 20-Day SMA (₹) | 661.8525 | ||
| 12-1 Month Momentum % | 23.95 | ||
| 52-Week Range (₹) | 461.7 - 884.95 | ||
| Shares Outstanding (Mil) | 158.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jubilant Ingrevia Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jubilant Ingrevia Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jubilant Ingrevia Ltd Frequently Asked Questions
What is Jubilant Ingrevia Ltd(BOM:543271)'s stock price today?
The current price of BOM:543271 is ₹632.95. The 52 week high of BOM:543271 is ₹884.95 and 52 week low is ₹461.70.
When is next earnings date of Jubilant Ingrevia Ltd(BOM:543271)?
The next earnings date of Jubilant Ingrevia Ltd(BOM:543271) is 2025-05-14 Est..
Does Jubilant Ingrevia Ltd(BOM:543271) pay dividends? If so, how much?
The Dividend Yield %  of Jubilant Ingrevia Ltd(BOM:543271) is 0.79% (As of Today), Highest Dividend Payout Ratio of Jubilant Ingrevia Ltd(BOM:543271) was 0.42. The lowest was 0.09. And the median was 0.26. The  Forward Dividend Yield % of Jubilant Ingrevia Ltd(BOM:543271) is 0.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers